199 related articles for article (PubMed ID: 20821187)
1. Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice.
Liu Y; Tanabe K; Baronnier D; Patel S; Woodgett J; Cras-Méneur C; Permutt MA
Diabetologia; 2010 Dec; 53(12):2600-10. PubMed ID: 20821187
[TBL] [Abstract][Full Text] [Related]
2. Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.
Tanabe K; Liu Z; Patel S; Doble BW; Li L; Cras-Méneur C; Martinez SC; Welling CM; White MF; Bernal-Mizrachi E; Woodgett JR; Permutt MA
PLoS Biol; 2008 Feb; 6(2):e37. PubMed ID: 18288891
[TBL] [Abstract][Full Text] [Related]
3. Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferation.
Liu Z; Tanabe K; Bernal-Mizrachi E; Permutt MA
Diabetologia; 2008 Apr; 51(4):623-31. PubMed ID: 18219478
[TBL] [Abstract][Full Text] [Related]
4. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.
Fornoni A; Pileggi A; Molano RD; Sanabria NY; Tejada T; Gonzalez-Quintana J; Ichii H; Inverardi L; Ricordi C; Pastori RL
Diabetologia; 2008 Feb; 51(2):298-308. PubMed ID: 18066521
[TBL] [Abstract][Full Text] [Related]
6. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.
Patel S; Doble BW; MacAulay K; Sinclair EM; Drucker DJ; Woodgett JR
Mol Cell Biol; 2008 Oct; 28(20):6314-28. PubMed ID: 18694957
[TBL] [Abstract][Full Text] [Related]
8. Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice.
Shojima N; Hara K; Fujita H; Horikoshi M; Takahashi N; Takamoto I; Ohsugi M; Aburatani H; Noda M; Kubota N; Yamauchi T; Ueki K; Kadowaki T
Diabetologia; 2012 Dec; 55(12):3318-30. PubMed ID: 22983607
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
10. Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats.
Figeac F; Uzan B; Faro M; Chelali N; Portha B; Movassat J
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E245-56. PubMed ID: 19920216
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GSK-3β restores delayed gastric emptying in obesity-induced diabetic female mice.
Sampath C; Srinivasan S; Freeman ML; Gangula PR
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G481-G493. PubMed ID: 32812777
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.
Tanioka T; Tamura Y; Fukaya M; Shinozaki S; Mao J; Kim M; Shimizu N; Kitamura T; Kaneki M
J Biol Chem; 2011 Aug; 286(33):29388-29396. PubMed ID: 21700708
[TBL] [Abstract][Full Text] [Related]
13. The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity.
Henriksen EJ; Teachey MK; Lindborg KA; Diehl CJ; Beneze AN
Am J Physiol Regul Integr Comp Physiol; 2008 Jun; 294(6):R1813-21. PubMed ID: 18385470
[TBL] [Abstract][Full Text] [Related]
14. Glutaredoxin 2 (GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury: A mechanism involving GSK-3β.
Wohua Z; Weiming X
Biomed Pharmacother; 2019 Oct; 118():108940. PubMed ID: 31382130
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
16. GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.
Desai SS; Modali SD; Parekh VI; Kebebew E; Agarwal SK
J Biol Chem; 2014 Feb; 289(9):5386-98. PubMed ID: 24425879
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase C-ζ in pancreatic β-cells in vivo improves glucose tolerance and induces β-cell expansion via mTOR activation.
Velazquez-Garcia S; Valle S; Rosa TC; Takane KK; Demirci C; Alvarez-Perez JC; Mellado-Gil JM; Ernst S; Scott DK; Vasavada RC; Alonso LC; Garcia-Ocaña A
Diabetes; 2011 Oct; 60(10):2546-59. PubMed ID: 21911744
[TBL] [Abstract][Full Text] [Related]
18. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
19. GSK-3β function in bone regulates skeletal development, whole-body metabolism, and male life span.
Gillespie JR; Bush JR; Bell GI; Aubrey LA; Dupuis H; Ferron M; Kream B; DiMattia G; Patel S; Woodgett JR; Karsenty G; Hess DA; Beier F
Endocrinology; 2013 Oct; 154(10):3702-18. PubMed ID: 23904355
[TBL] [Abstract][Full Text] [Related]
20. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression.
Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F
Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
